Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection

Caplin Point Laboratories arm gets USFDA nod for Neostigmine Methylsulfate Injection Neostigmine Methylsulfate Injection is a cholinesterase inhibitor and is indicated for the reversal of the effects of non-depolariSing neuromuscular blocking agents (NMBAs) after surgery.

No comments:

Post a Comment